Clinical Trial Update: Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation [Phase 4]

View source ↗

Summary

Phase 4 clinical study evaluating individualized administration of anti-thymocyte globulin (rATG) in haploidentical hematopoietic stem cell transplantation for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematopoietic Stem Cell Transplantation
• Leukemia

Drugs mentioned

• rATG (rabbit anti-thymocyte globulin)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Hematopoietic Stem Cell Transplantation, Acute Leukemia | Phase 4 | Status: UNKNOWN